([18F]-DOPA)
([18F]-DOPA) is a pharmaceutical drug with 11 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
5
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Diagnosis of Pheochromocytoma
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Natural History of Familial Carcinoid Tumor
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Clinical Trials (11)
Diagnosis of Pheochromocytoma
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Natural History of Familial Carcinoid Tumor
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
18F-DOPA II - PET Imaging Optimization
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
Studies of Elevated Parathyroid Activity
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11